Will Murky Trial Data Undercut Landos' $100 Million IPO Launch?

Landos Biopharma filed yesterday with the U.S. Securities and Exchange Commission (SEC) to launch an initial public offering (IPO). The company intends to raise $100 million. The company is a spinout from Virginia Tech, and a lead company in Chris Garabedian’s fund at Perceptive Advisors.